BRIEF

on MeVis Medical Solutions AG (isin : DE000A0LBFE4)

MeVis Medical Solutions AG Adjusts Forecast for 2023/2024

Stock price chart of MeVis Medical Solutions AG (EBR:M3V) showing fluctuations.

On September 4, 2024, MeVis Medical Solutions AG, a key player in medical imaging software, announced an adjustment in its financial forecast for the current fiscal year. Based on the preliminary figures for the first eleven months, the company expects sales to remain stable between € 17.0 million and € 17.5 million. This revises their earlier prediction of a slight increase to € 18.0 million to € 18.5 million.

The EBIT is now projected to drop to between € 3.0 million and € 3.5 million, down from the previously expected stability at € 4.5 million to € 5.0 million. The downward revision stems from a cautious purchasing behavior influenced by global economic challenges and the impact of the US dollar/euro exchange rate fluctuations.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all MeVis Medical Solutions AG news